Buy Minerva Neurosciences Stock | NERV Stock Price & Latest News | Public.com
NERV

Minerva Neurosciences

$0.00 (0.00%)Today
    Small Market Cap
    View Minerva Neurosciences (NERV) stock trends here

    About NERV

    Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product pipeline includes Roluperidone, Seltorexant, MIN-...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.73
    0.42
    0.11
    -0.19
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $0.41

    Actual EPS
    Q1 2021

    Stats

    Market Cap$120,76M
    Volume110,65k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.21
    1 Year Low$1.81
    Open$2.89
    High$2.89
    Low$2.66

    Buy any stock with any amount of money.

    Download the App
    Download the app